Göran Tornling
ORCID: 0000-0002-8718-6631
· 1 paper in corpus
article
2025
Abstract Study question Evaluation of vipoglanstat, a potent and selective mPGES-1 inhibitor, as a potential new non-hormonal, non-opioid oral treatment for endometriosis. Summary answer Vipoglanstat is safe and tolerable at doses anticipat…